EP2708213A1 — Multipurpose ethylene vinyl acetate fibrous drug delivery systems for long-term implantation or insertion
Assigned to PAT&Co bvba · Expires 2014-03-19 · 12y expired
What this patent protects
A multipurpose, multicomponent or multisegmented drug intrauterine T-shaped delivery system or device, of which both the stem and the transverse arm of the device are drug eluting compartments which are active in the uterus and/or the cervical canal. The drugs may be different an…
USPTO Abstract
A multipurpose, multicomponent or multisegmented drug intrauterine T-shaped delivery system or device, of which both the stem and the transverse arm of the device are drug eluting compartments which are active in the uterus and/or the cervical canal. The drugs may be different and/or have different concentration and releasing characteristics. The stem is preferably provided with a dome-shaped extremity. The stem and/or the transverse arm consist of ethylene vinyl acetate which contains a level of vinyl acetate monomer lower than 0.5% w/w.
Drugs covered by this patent
- Estrace (ESTRADIOL) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.